Stay updated on AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedA new revision v3.3.4 was added and the previous revision v3.3.3 was removed from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page history now includes Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a new revision (v3.3.2) and removed an older revision (v3.2.0) from the Study Record Versions list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe banner about government funding and operations has been removed from the page, and the study information remains unchanged.SummaryDifference0.7%

- Check81 days agoChange DetectedThe core historical data and version history remain unchanged; only minor UI/layout differences are visible between the old and new screenshots.SummaryDifference0.1%

- Check103 days agoChange DetectedUpdated version to v3.2.0 and added a government-status notice; removed the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 & Chiauranib Combo in Small Cell Lung Cancer Clinical Trial page.